Genetic Signatures sales rise on increases Covid-19 testing
Molecular diagnostic company Genetic Signatures has reported year to date sales of $23 million for the nine months to March 31, more than double its full year revenue in the previous financial year. Third quarter sales were $4.3 million including instrument sales of $300,000, up 136 per cent on the previous corresponding period. The company…